首页> 外文期刊>Medical principles and practice: international journal of the Kuwait University, Health Science Centre >Gene Expression of Aurora Kinases in Prostate Cancer and Nodular Hyperplasia Tissues
【24h】

Gene Expression of Aurora Kinases in Prostate Cancer and Nodular Hyperplasia Tissues

机译:前列腺癌和结节性增生组织中极光激酶的基因表达

获取原文
           

摘要

Objective: To measure the transcript levels of Aurora kinases and compare them to their immunoreactivity patterns in prostate tumors. Materials and Methods: A total of 26 cases of prostate cancer (PCa) and 38 cases of benign nodular hyperplasia (BPH) were sampled from archived formalin-fixed paraffin-embedded tissues. Tissue sections were lysed, total RNA extracted and cDNA made by random hexamer priming while slide sections were immunostained for the kinases. Normalized relative quantitation was performed for all the kinases using real-time PCR on TaqMan chemistry. Results: The immunoreactivity profile showed 15.4, 53.8 and 30.7% positivity for Aurora kinases A, B and C in PCa cases, respectively, while the positivity was 76.3, 73.7 and 84.2% for the same kinases in BPH cases. The immunoreactivity was preponderant on epithelial tissue compared to stromal component. Conclusion: Aurora kinases were significantly overexpressed in BPH cases compared to PCa cases. At the transcript level, there was no significant differential expression in the kinases between PCa and BPH cases.
机译:目的:测量Aurora激酶的转录水平并将其与前列腺肿瘤的免疫反应模式进行比较。材料与方法:从已归档的福尔马林固定石蜡包埋的组织中取样总共26例前列腺癌(PCa)和38例良性结节性增生(BPH)。裂解组织切片,提取总RNA,并通过随机六聚体引发制备cDNA,同时对玻片切片进行激酶免疫染色。使用TaqMan化学上的实时PCR对所有激酶进行标准化相对定量。结果:在PCa病例中,Aurora激酶A,B和C的阳性反应率分别为15.4、53.8和30.7%,而在BPH病例中,相同激酶的阳性率分别为76.3、73.7和84.2%。与基质成分相比,免疫反应在上皮组织上占优势。结论:与PCa病例相比,BPH病例中Aurora激酶明显过表达。在转录本水平上,PCa和BPH病例之间的激酶没有明显的差异表达。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号